Application completed Purchase Artemis Pharma // Turkish Market // Bosnian & Osimertinib
페이지 정보
본문
Author information
| Name | Arife Kusbaz |
|---|---|
| Phone number | 905-3255-7589 |
| arife.kusbaz@artemispharma.com.tr |
Inquiry content
Dear Sir or Madam,
My name is Arife Kuşbaz, Founder and General Manager of Artemis Pharma, based in Istanbul, Türkiye. I have extensive experience in the Turkish pharmaceutical market, particularly in representation and business development.
Building on this experience, Artemis Pharma focuses on establishing transparent, reliable, and sustainable partnerships between global manufacturers and Turkish pharmaceutical companies, with a strong emphasis on API and FDF sourcing, as well as operational project management.
Currently, I am looking for Bosentan & Osimertinib for one of my customers, and came across your company during my research. Also, your other products suit Turkish market.
Before proceeding further, could you kindly confirm:
Do you have any direct or indirect relationships with Turkish customers?
Building on this experience, Artemis Pharma focuses on establishing transparent, reliable, and sustainable partnerships between global manufacturers and Turkish pharmaceutical companies, with a strong emphasis on API and FDF sourcing, as well as operational project management.
Currently, I am looking for Bosentan & Osimertinib for one of my customers, and came across your company during my research. Also, your other products suit Turkish market.
Before proceeding further, could you kindly confirm:
Do you have any direct or indirect relationships with Turkish customers?
Can we work with commission basis?
If suitable, I would be pleased to discuss how we can structure a mutually beneficial cooperation.
Looking forward to your reply.
Best Regards,
Arife
If suitable, I would be pleased to discuss how we can structure a mutually beneficial cooperation.
Looking forward to your reply.
Best Regards,
Arife
첨부파일
-
Artemis_company_profile[3519498].pdf (390.7K)
0회 다운로드 | DATE : 2026-03-18 16:40:14
답변목록
There are no registered answers.
- Previous postPurchasing Specialist 26.03.19
- Next postInquiry_ Felbinac BP_ Beacon Pharmaceuticals PLC 26.03.10
